Literature DB >> 17245437

Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105-125.

Aimin Li1, Heather M Christensen, Leanne R Stewart, Kevin A Roth, Roberto Chiesa, David A Harris.   

Abstract

To identify sequence domains important for the neurotoxic and neuroprotective activities of the prion protein (PrP), we have engineered transgenic mice that express a form of murine PrP deleted for a conserved block of 21 amino acids (residues 105-125) in the unstructured, N-terminal tail of the protein. These mice spontaneously developed a severe neurodegenerative illness that was lethal within 1 week of birth in the absence of endogenous PrP. This phenotype was reversed in a dose-dependent fashion by coexpression of wild-type PrP, with five-fold overexpression delaying death beyond 1 year. The phenotype of Tg(PrPDelta105-125) mice is reminiscent of, but much more severe than, those described in mice that express PrP harboring larger deletions of the N-terminus, and in mice that ectopically express Doppel, a PrP paralog, in the CNS. The dramatically increased toxicity of PrPDelta105-125 is most consistent with a model in which this protein has greatly enhanced affinity for a hypothetical receptor that serves to transduce the toxic signal. We speculate that altered binding interactions involving the 105-125 region of PrP may also play a role in generating neurotoxic signals during prion infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17245437      PMCID: PMC1783448          DOI: 10.1038/sj.emboj.7601507

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  57 in total

1.  A transmembrane form of the prion protein contains an uncleaved signal peptide and is retained in the endoplasmic Reticulum.

Authors:  R S Stewart; B Drisaldi; D A Harris
Journal:  Mol Biol Cell       Date:  2001-04       Impact factor: 4.138

2.  Lack of prion protein expression results in a neuronal phenotype sensitive to stress.

Authors:  David R Brown; Richard St J Nicholas; Laura Canevari
Journal:  J Neurosci Res       Date:  2002-01-15       Impact factor: 4.164

3.  Identification of a novel gene encoding a PrP-like protein expressed as chimeric transcripts fused to PrP exon 1/2 in ataxic mouse line with a disrupted PrP gene.

Authors:  A Li; S Sakaguchi; R Atarashi; B C Roy; R Nakaoke; K Arima; N Okimura; J Kopacek; K Shigematsu
Journal:  Cell Mol Neurobiol       Date:  2000-10       Impact factor: 5.046

4.  NMR solution structure of the human prion protein.

Authors:  R Zahn; A Liu; T Lührs; R Riek; C von Schroetter; F López García; M Billeter; L Calzolai; G Wider; K Wüthrich
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

5.  Doppel-induced cerebellar degeneration in transgenic mice.

Authors:  R C Moore; P Mastrangelo; E Bouzamondo; C Heinrich; G Legname; S B Prusiner; L Hood; D Westaway; S J DeArmond; P Tremblay
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-04       Impact factor: 11.205

6.  Two different neurodegenerative diseases caused by proteins with similar structures.

Authors:  H Mo; R C Moore; F E Cohen; D Westaway; S B Prusiner; P E Wright; H J Dyson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

7.  Prion protein protects human neurons against Bax-mediated apoptosis.

Authors:  Y Bounhar; Y Zhang; C G Goodyer; A LeBlanc
Journal:  J Biol Chem       Date:  2001-08-24       Impact factor: 5.157

8.  A transmembrane form of the prion protein in neurodegenerative disease.

Authors:  R S Hegde; J A Mastrianni; M R Scott; K A DeFea; P Tremblay; M Torchia; S J DeArmond; S B Prusiner; V R Lingappa
Journal:  Science       Date:  1998-02-06       Impact factor: 47.728

9.  Onset of ataxia and Purkinje cell loss in PrP null mice inversely correlated with Dpl level in brain.

Authors:  D Rossi; A Cozzio; E Flechsig; M A Klein; T Rülicke; A Aguzzi; C Weissmann
Journal:  EMBO J       Date:  2001-02-15       Impact factor: 11.598

10.  Cross-linking cellular prion protein triggers neuronal apoptosis in vivo.

Authors:  Laura Solforosi; Jose R Criado; Dorian B McGavern; Sebastian Wirz; Manuel Sánchez-Alavez; Shuei Sugama; Lorraine A DeGiorgio; Bruce T Volpe; Erika Wiseman; Gil Abalos; Eliezer Masliah; Donald Gilden; Michael B Oldstone; Bruno Conti; R Anthony Williamson
Journal:  Science       Date:  2004-01-29       Impact factor: 47.728

View more
  105 in total

Review 1.  Prion protein at the crossroads of physiology and disease.

Authors:  Emiliano Biasini; Jessie A Turnbaugh; Ursula Unterberger; David A Harris
Journal:  Trends Neurosci       Date:  2011-12-01       Impact factor: 13.837

Review 2.  Prion potency in stem cells biology.

Authors:  Marilene H Lopes; Tiago G Santos
Journal:  Prion       Date:  2012-04-01       Impact factor: 3.931

3.  Memory impairment in transgenic Alzheimer mice requires cellular prion protein.

Authors:  David A Gimbel; Haakon B Nygaard; Erin E Coffey; Erik C Gunther; Juha Laurén; Zachary A Gimbel; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

4.  A nine amino acid domain is essential for mutant prion protein toxicity.

Authors:  Laura Westergard; Jessie A Turnbaugh; David A Harris
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

Review 5.  Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.

Authors:  Julie A Moreno; Glenn C Telling
Journal:  Methods Mol Biol       Date:  2017

6.  De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis.

Authors:  Christina J Sigurdson; K Peter R Nilsson; Simone Hornemann; Mathias Heikenwalder; Giuseppe Manco; Petra Schwarz; David Ott; Thomas Rülicke; Pawel P Liberski; Christian Julius; Jeppe Falsig; Lothar Stitz; Kurt Wüthrich; Adriano Aguzzi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-10       Impact factor: 11.205

7.  Perturbation of T-cell development by insertional mutation of a PrP transgene.

Authors:  Mark Zabel; Christina Greenwood; Alana M Thackray; Bruce Pulford; Willem Rens; Raymond Bujdoso
Journal:  Immunology       Date:  2008-10-21       Impact factor: 7.397

8.  Dominant-negative effects of the N-terminal half of prion protein on neurotoxicity of prion protein-like protein/doppel in mice.

Authors:  Daisuke Yoshikawa; Naohiro Yamaguchi; Daisuke Ishibashi; Hitoki Yamanaka; Nobuhiko Okimura; Yoshitaka Yamaguchi; Tsuyoshi Mori; Hironori Miyata; Kazuto Shigematsu; Shigeru Katamine; Suehiro Sakaguchi
Journal:  J Biol Chem       Date:  2008-06-18       Impact factor: 5.157

9.  Context dependent neuroprotective properties of prion protein (PrP).

Authors:  Andrew D Steele; Zhipeng Zhou; Walker S Jackson; Chunni Zhu; Pavan Auluck; Michael A Moskowitz; Marie-Francoise Chesselet; Susan Lindquist
Journal:  Prion       Date:  2009-10-16       Impact factor: 3.931

Review 10.  Beta-amyloid oligomers and cellular prion protein in Alzheimer's disease.

Authors:  Erik C Gunther; Stephen M Strittmatter
Journal:  J Mol Med (Berl)       Date:  2009-12-04       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.